Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters

被引:28
|
作者
Benki, Sarah
McClelland, R. Scott
Emery, Sandra
Baeten, Jared M.
Richardson, Barbra A.
Lavreys, Ludo
Mandaliya, Kishorchandra
Overbaugh, Julie
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[6] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[7] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[8] Coast Provincial Gen Hosp, Mombasa, Kenya
关键词
D O I
10.1128/JCM.01481-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Studies of human immunodeficiency virus type 1 (HIV-1) transmission suggest that genital HIV-1 RNA and DNA may both be determinants of HIV-1 infectivity. Despite its potential role in HIV-1 transmission, there are limited quantitative data on genital HIV-1 DNA. Here we validated an in-house real-time PCR method for quantification of HIV-1 DNA in genital specimens. In reactions with 100 genomes to 1 genome isolated from a cell line containing one HIV-1 provirus/cell, this real-time PCR assay is linear and agrees closely with a commercially available real-time PCR assay specific for a cellular housekeeping gene. In mock genital samples spiked with low numbers of HIV-1-infected cells such that the expected HIV-1 DNA copy number/reaction was 100, 10, or 5, the average copy number/reaction was 80.2 (standard deviation [SD], 28.3), 9.1 (SD, 5.4), or 3.1 (SD, 2.1), respectively. We used this method to examine genital HIV-1 DNA levels in specimens from women whose low plasma HIV-1 RNA levels are typical of HIV-1 nontransmitters. The median HIV-1 DNA copy number in endocervical secretions from these women (1.8 HIV-1 DNA copies/10,000 cells) was lower than that for women with higher plasma HIV-1 RNA levels (16.6 HIV-1 DNA copies/10,000 cells) (P = 0.04), as was the median HIV-1 DNA copy number in vaginal secretions (undetectable versus 1.0 HIV-1 DNA copies/10,000 cells). These data suggest that women with low plasma HIV-1 RNA and thus a predicted low risk of HIV-1 transmission have low levels of genital HIV-1 cell-associated virus. The assay described here can be utilized in future efforts to examine the role of cell-associated HIV-1 in transmission.
引用
收藏
页码:4357 / 4362
页数:6
相关论文
共 50 条
  • [41] Redox regulation of the human immunodeficiency virus type 1 (HIV-1).
    Piette, J
    Sappey, C
    Piret, B
    LegrandPoels, S
    [J]. DNA AND RNA CLEAVERS AND CHEMOTHERAPY OF CANCER AND VIRAL DISEASES, 1996, 479 : 249 - 268
  • [42] Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell
    Morizono, K
    Harada, S
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (04) : 313 - 320
  • [43] Quantification by additive RT-PCR of HIV-1 RNA plasma levels in different stages of HIV-1 infection
    Fernandez-Arcas, N
    Dieguez-Lucena, JL
    Costa, AF
    Garcia-Villanova, J
    Ruiz-Galdon, M
    Pena, J
    Morell, M
    Reyes-Engel, A
    [J]. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 1997, 53 (03) : 307 - 315
  • [44] Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test
    Vandamme, AM
    Schmit, JC
    VanDooren, S
    VanLaethem, K
    Gobbers, E
    Kok, W
    Goubau, P
    Witvrouw, M
    Peetermans, W
    DeClercq, E
    Desmyter, J
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 13 (02) : 127 - 139
  • [45] Evaluation of the nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma
    Segondy, M
    Ly, TD
    Lapeyre, M
    Montes, B
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) : 3372 - 3374
  • [46] Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
    Kotler, M
    Simm, M
    Zhao, YS
    Sova, P
    Chao, W
    Ohnona, SF
    Roller, R
    Krachmarov, C
    Potash, MJ
    Volsky, DJ
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (08) : 5774 - 5781
  • [47] Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda
    Cao, HY
    Mani, I
    Vincent, R
    Mugerwa, R
    Mugyenyi, P
    Kanki, P
    Ellner, J
    Walker, BD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05): : 1350 - 1356
  • [48] Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection
    Rieder, Philip
    Joos, Beda
    Scherrer, Alexandra U.
    Kuster, Herbert
    Braun, Dominique
    Grube, Christina
    Niederoest, Barbara
    Leemann, Christine
    Gianella, Sara
    Metzner, Karin J.
    Boeni, Juerg
    Weber, Rainer
    Guenthard, Huldrych F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (12) : 1271 - 1279
  • [49] Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes
    Beels, Dominique
    Heyndrick, Leo
    Vereecken, Katleen
    Vermoesen, Tine
    Michiels, Lieve
    Vanham, Guido
    Kestens, Luc
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (01) : 99 - 107
  • [50] DETECTION OF HIV-1 RNA IN HEPARINIZED PLASMA OF HIV-1 SEROPOSITIVE INDIVIDUALS
    IMAI, H
    YAMADA, O
    MORITA, S
    SUEHIRO, S
    KURIMURA, T
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1992, 36 (02) : 181 - 184